Table 1:
Characteristics of respondents, by survey period
| May 2021 (n=114) no. (%) |
September 2022 (n=131) no. (%) |
p value | |
|---|---|---|---|
| Demographics | |||
| Age <40 years | 57 (50.0) | 58 (44.3) | 0.37 |
| Gender | 0.91 | ||
| Men | 53 (46.5) | 60 (45.8) | |
| Women/Othera | 61 (53.5) | 71 (54.2) | |
| Profession | 0.71 | ||
| APPsb | 47 (41.2) | 51 (38.9) | |
| Physicians | 67 (58.8) | 80 (61.1) | |
| Living situation during pandemic | 0.41 | ||
| Lived alone | 14 (12.3) | 10 (7.7) | |
| Lived with 1–4 members | 93 (81.6) | 109 (83.8) | |
| Lived with 5–10 members | 7 (6.1) | 11 (8.5) | |
| People living with you during pandemicc | |||
| Children | 66 (57.9) | 76 (58.0) | 0.98 |
| Parents | 13 (11.4) | 13 (9.9) | 0.71 |
| Spouse, partner, or significant other | 92 (80.7) | 116 (88.5) | 0.09 |
| Worked <4 weeks | 39 (34.2) | 42 (32.3) | 0.75 |
| COVID-19 | |||
| Primary source for COVID-19 information | |||
| News websites | 25 (21.9) | 17 (13.0) | |
| Social medial platforms | 1 (0.9) | 2 (1.5) | |
| Institutional resources | 81 (71.1) | 98 (74.8) | |
| Discussion with family and friends | 0 (0.0) | 2 (1.5) | |
| Other | 7 (6.1) | 12 (9.2) | |
| Cared for patients with known or suspected COVID-19 | 90 (80.4) | 112 (86.8) | 0.17 |
| Concerned about contracting COVID-19 at workd | 31 (27.2) | 39 (29.8) | 0.66 |
| Changed where you lived due to fear of transmitting COVID-19 to family members | 2 (1.8) | 3 (2.3) | |
| Global well-being e | |||
| Mental health | 78 (68.4) | 74 (57.4) | 0.08 |
| Social activities and relationships | 49 (43.8) | 58 (44.3) | 0.93 |
| Mpox | |||
| Concerned about contracting Mpox in communityd | --- | 6 (4.6) | --- |
| Concerned about contracting Mpox at workd | --- | 13 (9.9) | --- |
| Primary source for Mpox information | --- | --- | |
| News websites | 41 (31.3) | ||
| Social medial platforms | 4 (3.1) | ||
| Institutional resources | 74 (56.5) | ||
| Discussion with family and friends | 2 (1.5) | ||
| Other | 10 (7.6) | ||
| Responsibility to provide Mpox informationc | --- | --- | |
| My responsibility | 71 (54.2) | ||
| Hospital Medicine leadership | 64 (48.9) | ||
| Mayo Clinic leadership | 96 (73.3) | ||
| Centers for Disease Control and Prevention | 110 (84.0) | ||
| US Food and Drug Administration | 16 (12.2) | ||
| Helpful for Hospital Medicine leadership to conduct ≥1 Mpox sessiond | --- | 71 (54.2) | --- |
For each survey period, ‘during pandemic’ and questions referred to the preceding six-week period: May 2021 (March 15, 2021–April 30, 2021) and September 2022 (August 1, 2022–September 15, 2022). Percentages may not add to 100 due to rounding.
Mpox questions were asked only in the September 2022 survey.
Other included non-binary/other, prefer not to respond, and missing.
Advanced practice providers (APPs) refer to nurse practitioners and physician assistants.
Respondents could select more than one option.
Agree included strongly agree and agree; other included neutral, disagree, and strongly disagree.
Options were excellent, very good, good, fair, and poor. Top global well-being included excellent and very good.
p value based on chi-square or Fisher test.
Data missing: living situation during pandemic (n=1), worked <4 weeks (n=1), cared for patients with known or suspected COVID-19 (n=4), changed where you lived due to fear of transmitting COVID-19 to family members (n=3), global well-being–mental health (n=2) and global health–social activities and relationship (n=2).
Survey questions listed in Supplement 1.
Abbreviation: COVID-19, Coronavirus disease 2019.